Trials / Completed
CompletedNCT06620744
Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- SB Technology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective device study will examine the feasibility of MCG data collection in a hospital setting using the SandboxAQ MCG device as a potential method to more accurately and quickly quantify cardiac disease of patients with elevated Troponin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sponsor MCG deivce | Unshielded device measuring cardiac magnetic fields. |
Timeline
- Start date
- 2024-09-21
- Primary completion
- 2025-04-15
- Completion
- 2025-04-15
- First posted
- 2024-10-01
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06620744. Inclusion in this directory is not an endorsement.